首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
A phase I study of intravenous (IV) milataxel in combination with carboplatin in adult patients with advanced malignant solid tumors
被引:0
|
作者
:
Flood, W. A.
论文数:
0
引用数:
0
h-index:
0
机构:
Penn State Hershey Canc Inst, Hershey, PA USA
Dartmouth Med Sch, Lebanon, NH USA
Penn State Hershey Canc Inst, Hershey, PA USA
Flood, W. A.
[
1
,
2
]
Lewis, L. D.
论文数:
0
引用数:
0
h-index:
0
机构:
Penn State Hershey Canc Inst, Hershey, PA USA
Dartmouth Med Sch, Lebanon, NH USA
Penn State Hershey Canc Inst, Hershey, PA USA
Lewis, L. D.
[
1
,
2
]
机构
:
[1]
Penn State Hershey Canc Inst, Hershey, PA USA
[2]
Dartmouth Med Sch, Lebanon, NH USA
来源
:
JOURNAL OF CLINICAL ONCOLOGY
|
2009年
/ 27卷
/ 15期
关键词
:
D O I
:
暂无
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
e13525
引用
收藏
页数:2
相关论文
共 50 条
[21]
A phase I study of intravenous artesunate (IV AS) in patients with solid tumors.
Deeken, John F.
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Deeken, John F.
Wang, Hongkun
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Wang, Hongkun
Smaglo, Brandon George
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Smaglo, Brandon George
Hwang, Jimmy J.
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Hwang, Jimmy J.
He, Aiwu Ruth
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
He, Aiwu Ruth
Weiner, Louis M.
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Weiner, Louis M.
Marshall, John
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Marshall, John
Giaccone, Giuseppe
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Giaccone, Giuseppe
Liu, Stephen V.
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Liu, Stephen V.
Luecht, Jim
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Luecht, Jim
Urso, Christina
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Urso, Christina
Spiegel, Jay Y.
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Spiegel, Jay Y.
Cheema, Amrita
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Cheema, Amrita
Pishvaian, Michael J.
论文数:
0
引用数:
0
h-index:
0
机构:
Inova Comprehens Canc & Res Inst, Mclean, VA USA
Pishvaian, Michael J.
JOURNAL OF CLINICAL ONCOLOGY,
2015,
33
(15)
[22]
Gemcitabine and carboplatin combination in advanced solid tumors: A phase I trial.
Tassinari, D
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp, Dept Oncol, Rimini, Italy
City Hosp, Dept Oncol, Rimini, Italy
Tassinari, D
Pasini, G
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp, Dept Oncol, Rimini, Italy
City Hosp, Dept Oncol, Rimini, Italy
Pasini, G
Arcangeli, V
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp, Dept Oncol, Rimini, Italy
City Hosp, Dept Oncol, Rimini, Italy
Arcangeli, V
Panzini, I
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp, Dept Oncol, Rimini, Italy
City Hosp, Dept Oncol, Rimini, Italy
Panzini, I
Drudi, G
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp, Dept Oncol, Rimini, Italy
City Hosp, Dept Oncol, Rimini, Italy
Drudi, G
Gianni, L
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp, Dept Oncol, Rimini, Italy
City Hosp, Dept Oncol, Rimini, Italy
Gianni, L
Oliverio, G
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp, Dept Oncol, Rimini, Italy
City Hosp, Dept Oncol, Rimini, Italy
Oliverio, G
Sartori, S
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp, Dept Oncol, Rimini, Italy
City Hosp, Dept Oncol, Rimini, Italy
Sartori, S
Fochessati, F
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp, Dept Oncol, Rimini, Italy
City Hosp, Dept Oncol, Rimini, Italy
Fochessati, F
ANNALS OF ONCOLOGY,
2000,
11
: 141
-
141
[23]
A Phase I and Pharmacokinetic Study of Ixabepilone in Combination with Carboplatin in Patients with Advanced Solid Malignancies
Plummer, Ruth
论文数:
0
引用数:
0
h-index:
0
机构:
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Plummer, Ruth
Woll, Penella
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp Nottingham, Nottingham, England
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Woll, Penella
Fyfe, David
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp Nottingham, Nottingham, England
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Fyfe, David
Boddy, Alan V.
论文数:
0
引用数:
0
h-index:
0
机构:
No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Boddy, Alan V.
Griffin, Melanie
论文数:
0
引用数:
0
h-index:
0
机构:
No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Griffin, Melanie
Hewitt, Paula
论文数:
0
引用数:
0
h-index:
0
机构:
Bristol Myers Squibb Co, Uxbridge, Middx, England
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Hewitt, Paula
Carmichael, James
论文数:
0
引用数:
0
h-index:
0
机构:
City Hosp Nottingham, Nottingham, England
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Carmichael, James
Namouni, Fouad
论文数:
0
引用数:
0
h-index:
0
机构:
Bristol Myers Squibb Co, Wallingford, CT 06492 USA
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Namouni, Fouad
Cohen, Marvin
论文数:
0
引用数:
0
h-index:
0
机构:
Bristol Myers Squibb Co, Wallingford, CT 06492 USA
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Cohen, Marvin
Verrill, Mark
论文数:
0
引用数:
0
h-index:
0
机构:
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
No Ctr Canc Treatment, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Verrill, Mark
CLINICAL CANCER RESEARCH,
2008,
14
(24)
: 8288
-
8294
[24]
Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors
Vidal, Laura
论文数:
0
引用数:
0
h-index:
0
机构:
Royal Marsden Hosp, Drug Dev Unit, Inst Canc Res, Sutton SM2 5PT, Surrey, England
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Vidal, Laura
Magem, Margarita
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Magem, Margarita
Barlow, Clare
论文数:
0
引用数:
0
h-index:
0
机构:
Royal Marsden Hosp, Drug Dev Unit, Inst Canc Res, Sutton SM2 5PT, Surrey, England
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Barlow, Clare
Pardo, Beatriz
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Pardo, Beatriz
Florez, Amalia
论文数:
0
引用数:
0
h-index:
0
机构:
PharmaMar R&D, Madrid 28770, Spain
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Florez, Amalia
Montes, Ana
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Montes, Ana
Garcia, Margarita
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Garcia, Margarita
Judson, Ian
论文数:
0
引用数:
0
h-index:
0
机构:
Royal Marsden Hosp, Drug Dev Unit, Inst Canc Res, Sutton SM2 5PT, Surrey, England
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Judson, Ian
Lebedinsky, Claudia
论文数:
0
引用数:
0
h-index:
0
机构:
PharmaMar R&D, Madrid 28770, Spain
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Lebedinsky, Claudia
Kaye, Stan B.
论文数:
0
引用数:
0
h-index:
0
机构:
Royal Marsden Hosp, Drug Dev Unit, Inst Canc Res, Sutton SM2 5PT, Surrey, England
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Kaye, Stan B.
Salazar, Ramon
论文数:
0
引用数:
0
h-index:
0
机构:
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Inst Catala Oncol, Lhospitalet De Llobregat 08907, Spain
Salazar, Ramon
INVESTIGATIONAL NEW DRUGS,
2012,
30
(02)
: 616
-
628
[25]
Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors
Laura Vidal
论文数:
0
引用数:
0
h-index:
0
机构:
The Institute of Cancer Research,Drug Development Unit, Royal Marsden Hospital
Laura Vidal
Margarita Magem
论文数:
0
引用数:
0
h-index:
0
机构:
The Institute of Cancer Research,Drug Development Unit, Royal Marsden Hospital
Margarita Magem
Clare Barlow
论文数:
0
引用数:
0
h-index:
0
机构:
The Institute of Cancer Research,Drug Development Unit, Royal Marsden Hospital
Clare Barlow
Beatriz Pardo
论文数:
0
引用数:
0
h-index:
0
机构:
The Institute of Cancer Research,Drug Development Unit, Royal Marsden Hospital
Beatriz Pardo
Amalia Florez
论文数:
0
引用数:
0
h-index:
0
机构:
The Institute of Cancer Research,Drug Development Unit, Royal Marsden Hospital
Amalia Florez
Ana Montes
论文数:
0
引用数:
0
h-index:
0
机构:
The Institute of Cancer Research,Drug Development Unit, Royal Marsden Hospital
Ana Montes
Margarita Garcia
论文数:
0
引用数:
0
h-index:
0
机构:
The Institute of Cancer Research,Drug Development Unit, Royal Marsden Hospital
Margarita Garcia
Ian Judson
论文数:
0
引用数:
0
h-index:
0
机构:
The Institute of Cancer Research,Drug Development Unit, Royal Marsden Hospital
Ian Judson
Claudia Lebedinsky
论文数:
0
引用数:
0
h-index:
0
机构:
The Institute of Cancer Research,Drug Development Unit, Royal Marsden Hospital
Claudia Lebedinsky
Stan B. Kaye
论文数:
0
引用数:
0
h-index:
0
机构:
The Institute of Cancer Research,Drug Development Unit, Royal Marsden Hospital
Stan B. Kaye
Ramón Salazar
论文数:
0
引用数:
0
h-index:
0
机构:
The Institute of Cancer Research,Drug Development Unit, Royal Marsden Hospital
Ramón Salazar
Investigational New Drugs,
2012,
30
: 616
-
628
[26]
Phase I study of combination topotecan and carboplatin in pediatric solid tumors
Athale, UH
论文数:
0
引用数:
0
h-index:
0
机构:
St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
Athale, UH
Stewart, C
论文数:
0
引用数:
0
h-index:
0
机构:
St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
Stewart, C
Kuttesch, JF
论文数:
0
引用数:
0
h-index:
0
机构:
St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
Kuttesch, JF
Moghrabi, A
论文数:
0
引用数:
0
h-index:
0
机构:
St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
Moghrabi, A
Meyer, W
论文数:
0
引用数:
0
h-index:
0
机构:
St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
Meyer, W
Pratt, C
论文数:
0
引用数:
0
h-index:
0
机构:
St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
Pratt, C
Gajjar, A
论文数:
0
引用数:
0
h-index:
0
机构:
St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
Gajjar, A
Heideman, RL
论文数:
0
引用数:
0
h-index:
0
机构:
St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
Heideman, RL
JOURNAL OF CLINICAL ONCOLOGY,
2002,
20
(01)
: 88
-
95
[27]
Phase I Study of Pazopanib in Combination with Paclitaxel and Carboplatin Given Every 21 Days in Patients with Advanced Solid Tumors
Burris, Howard A., III
论文数:
0
引用数:
0
h-index:
0
机构:
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Burris, Howard A., III
Dowlati, Afshin
论文数:
0
引用数:
0
h-index:
0
机构:
Case Western Reserve Univ, Cleveland, OH 44106 USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Dowlati, Afshin
Moss, Rebecca A.
论文数:
0
引用数:
0
h-index:
0
机构:
Canc Inst New Jersey, New Brunswick, NJ USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Moss, Rebecca A.
Infante, Jeffrey R.
论文数:
0
引用数:
0
h-index:
0
机构:
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Infante, Jeffrey R.
Jones, Suzanne F.
论文数:
0
引用数:
0
h-index:
0
机构:
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Jones, Suzanne F.
Spigel, David R.
论文数:
0
引用数:
0
h-index:
0
机构:
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Spigel, David R.
Levinson, Kelly T.
论文数:
0
引用数:
0
h-index:
0
机构:
Canc Inst New Jersey, New Brunswick, NJ USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Levinson, Kelly T.
Lindquist, Diana
论文数:
0
引用数:
0
h-index:
0
机构:
Canc Inst New Jersey, New Brunswick, NJ USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Lindquist, Diana
Gainer, Shelby D.
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Res Triangle Pk, NC USA
GlaxoSmithKline, Upper Providence, PA USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Gainer, Shelby D.
Dar, Mohammed M.
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Res Triangle Pk, NC USA
GlaxoSmithKline, Upper Providence, PA USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Dar, Mohammed M.
Suttle, A. Benjamin
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Res Triangle Pk, NC USA
GlaxoSmithKline, Upper Providence, PA USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Suttle, A. Benjamin
Ball, Howard A.
论文数:
0
引用数:
0
h-index:
0
机构:
GlaxoSmithKline, Res Triangle Pk, NC USA
GlaxoSmithKline, Upper Providence, PA USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Ball, Howard A.
Tan, Antoinette R.
论文数:
0
引用数:
0
h-index:
0
机构:
Canc Inst New Jersey, New Brunswick, NJ USA
Sarah Cannon Res Inst, Nashville, TN 37203 USA
Tan, Antoinette R.
MOLECULAR CANCER THERAPEUTICS,
2012,
11
(08)
: 1820
-
1828
[28]
Phase I study of oral CI-994 in combination with carboplatin and paclitaxel in the treatment of patients with advanced solid tumors
Pauer, LR
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Global Res & Dev, Ann Arbor, MI USA
Pauer, LR
Olivares, J
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Global Res & Dev, Ann Arbor, MI USA
Olivares, J
Cunningham, C
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Global Res & Dev, Ann Arbor, MI USA
Cunningham, C
Williams, A
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Global Res & Dev, Ann Arbor, MI USA
Williams, A
Grove, W
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Global Res & Dev, Ann Arbor, MI USA
Grove, W
Kraker, G
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Global Res & Dev, Ann Arbor, MI USA
Kraker, G
Olson, S
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Global Res & Dev, Ann Arbor, MI USA
Olson, S
Nemunaitis, J
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Global Res & Dev, Ann Arbor, MI USA
Nemunaitis, J
CANCER INVESTIGATION,
2004,
22
(06)
: 886
-
896
[29]
Phase IB study of eribulin mesylate in combination with carboplatin in patients with advanced solid tumors.
Swami, U.
论文数:
0
引用数:
0
h-index:
0
机构:
Montefiore Canc Ctr, Bronx, NY USA
Swami, U.
Petrylak, D. P.
论文数:
0
引用数:
0
h-index:
0
机构:
Montefiore Canc Ctr, Bronx, NY USA
Petrylak, D. P.
Raftopoulos, H.
论文数:
0
引用数:
0
h-index:
0
机构:
Montefiore Canc Ctr, Bronx, NY USA
Raftopoulos, H.
Shuster, D. E.
论文数:
0
引用数:
0
h-index:
0
机构:
Montefiore Canc Ctr, Bronx, NY USA
Shuster, D. E.
Wang, G.
论文数:
0
引用数:
0
h-index:
0
机构:
Montefiore Canc Ctr, Bronx, NY USA
Wang, G.
Kumar, V.
论文数:
0
引用数:
0
h-index:
0
机构:
Montefiore Canc Ctr, Bronx, NY USA
Kumar, V.
Martinez, G.
论文数:
0
引用数:
0
h-index:
0
机构:
Montefiore Canc Ctr, Bronx, NY USA
Martinez, G.
Goel, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Montefiore Canc Ctr, Bronx, NY USA
Goel, S.
Alsner, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Montefiore Canc Ctr, Bronx, NY USA
Alsner, J.
JOURNAL OF CLINICAL ONCOLOGY,
2010,
28
(15)
[30]
Phase I Dose-Escalation Study of Intravenous Aflibercept in Combination with Docetaxel in Patients with Advanced Solid Tumors
Isambert, Nicolas
论文数:
0
引用数:
0
h-index:
0
机构:
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
Ctr Invest Clin Plurithemat 803, INSERM, CIC P 803, F-21079 Dijon, France
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
Isambert, Nicolas
Freyer, Gilles
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Lyon, Ctr Hosp Lyon Sud, Ctr Invest Therapeut Oncol & Hematol, Serv Oncol Med, Lyon, France
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
Freyer, Gilles
Zanetta, Sylvie
论文数:
0
引用数:
0
h-index:
0
机构:
Ctr Invest Clin Plurithemat 803, INSERM, CIC P 803, F-21079 Dijon, France
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
Zanetta, Sylvie
You, Benoit
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Lyon, Ctr Hosp Lyon Sud, Ctr Invest Therapeut Oncol & Hematol, Serv Oncol Med, Lyon, France
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
You, Benoit
Fumoleau, Pierre
论文数:
0
引用数:
0
h-index:
0
机构:
Ctr Invest Clin Plurithemat 803, INSERM, CIC P 803, F-21079 Dijon, France
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
Fumoleau, Pierre
Falandry, Claire
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Lyon, Ctr Hosp Lyon Sud, Ctr Invest Therapeut Oncol & Hematol, Serv Oncol Med, Lyon, France
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
Falandry, Claire
Favier, Laure
论文数:
0
引用数:
0
h-index:
0
机构:
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
Favier, Laure
Assadourian, Sylvie
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Oncol, Vitry Sur Seine, France
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
Assadourian, Sylvie
Soussan-Lazard, Karen
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Oncol, Vitry Sur Seine, France
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
Soussan-Lazard, Karen
Ziti-Ljajic, Samira
论文数:
0
引用数:
0
h-index:
0
机构:
Sanofi Aventis Oncol, Vitry Sur Seine, France
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
Ziti-Ljajic, Samira
Trillet-Lenoir, Veronique
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Lyon, Ctr Hosp Lyon Sud, Ctr Invest Therapeut Oncol & Hematol, Serv Oncol Med, Lyon, France
Ctr GF Leclerc, Dept Oncol Med, Unite Phases 1, F-21079 Dijon, France
Trillet-Lenoir, Veronique
CLINICAL CANCER RESEARCH,
2012,
18
(06)
: 1743
-
1750
←
1
2
3
4
5
→